# Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia

Study · id `cardio:ct-nct02791763` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02791763](<https://clinicaltrials.gov/study/NCT02791763>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02791763

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 355 participants.

## Technical summary

Registry record NCT02791763. Randomized; no masking; primary purpose treatment. Start 2016-06-06 (actual); primary completion 2018-10-26 (actual). Results posted on 2019-11-13.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 355 participants (enrolled count; ClinicalTrials.gov record NCT02791763, source copy `cardio:ctgov-nct02791763-2021-05-18`, retrieved 2026-10-26)
- Started: 2016-06-06 (actual) (ClinicalTrials.gov record NCT02791763, source copy `cardio:ctgov-nct02791763-2021-05-18`, retrieved 2026-10-26)
- Primary completion: 2018-10-26 (actual) (ClinicalTrials.gov record NCT02791763, source copy `cardio:ctgov-nct02791763-2021-05-18`, retrieved 2026-10-26)
- Completion: 2018-10-26 (actual) (ClinicalTrials.gov record NCT02791763, source copy `cardio:ctgov-nct02791763-2021-05-18`, retrieved 2026-10-26)
- Results first posted: 2019-11-13 (ClinicalTrials.gov record NCT02791763, source copy `cardio:ctgov-nct02791763-2021-05-18`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT02791763, source copy `cardio:ctgov-nct02791763-2021-05-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02791763-2021-05-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia
- Condition: Anaemia
- Intervention (Drug): 1 to 4 mg tablets of GSK1278863
- Intervention (Drug): 6 mg GSK1278863 tablet
- Intervention (Drug): Epoetin beta pegol
- Lead sponsor: GlaxoSmithKline
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: GlaxoSmithKline (`cardio:org-glaxosmithkline`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial (`cardio:pubmed-33561857`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: deeadef1aa503de39e3923b38d2aa155020da6b0a8439802cfb95c70c8920e80
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
